MSH6 and Lynch syndrome: Again, the co-occurrence of this pathogenic mutation with p.T767I in MSH6, the loss of MSH6 protein expression and other factors provided evidence to upgrade this VUS to a likely pathogenic variant and the diagnosis was upgraded to Lynch syndrome.